These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35639586)

  • 1. Influence of daptomycin doses on the outcomes of VRE bloodstream infection treated with high-dose daptomycin.
    Chuang YC; Lin HY; Yang JL; Lin CY; Huang SH; Wang JT; Chen YC; Chang SC
    J Antimicrob Chemother; 2022 Jul; 77(8):2278-2287. PubMed ID: 35639586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
    Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of daptomycin dose and fosfomycin susceptibility on outcome of vancomycin-resistant Enterococcus faecium bloodstream infections treated with daptomycin and fosfomycin combination.
    Chuang YC; Tseng TC; Wang JT; Lin CY; Huang SH; Chen YC; Chang SC
    J Antimicrob Chemother; 2022 Apr; 77(5):1436-1443. PubMed ID: 35141753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
    Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
    Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
    Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
    Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC
    Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.
    Britt NS; Potter EM; Patel N; Steed ME
    Clin Infect Dis; 2017 Mar; 64(5):605-613. PubMed ID: 28011602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
    Britt NS; Potter EM; Patel N; Steed ME
    Clin Infect Dis; 2015 Sep; 61(6):871-8. PubMed ID: 26063715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
    Britt NS; Potter EM; Patel N; Steed ME
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.
    Herc ES; Kauffman CA; Marini BL; Perissinotti AJ; Miceli MH
    Leuk Lymphoma; 2017 Dec; 58(12):2852-2858. PubMed ID: 28402152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of Patients With Vancomycin-Resistant Enterococcus faecium Bacteremia Treated With Conventional or High Doses of Daptomycin or Linezolid Is Associated With the Rate of Bacterial Clearance.
    Chuang YC; Lin HY; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
    Crit Care Med; 2018 Oct; 46(10):1634-1642. PubMed ID: 29957707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
    King EA; McCoy D; Desai S; Nyirenda T; Bicking K
    J Antimicrob Chemother; 2011 Sep; 66(9):2112-8. PubMed ID: 21697178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis.
    Zhao M; Liang L; Ji L; Chen D; Zhang Y; Zhu Y; Patel K
    Int J Antimicrob Agents; 2016 Sep; 48(3):231-8. PubMed ID: 27475877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin susceptibility testing and therapeutic use in enterococcal bloodstream infection (EBSI) in a setting with high rates of vancomycin-resistant Enterococcus faecium (VREfm).
    Kelly J; Tysall L; Dewar S
    J Antimicrob Chemother; 2022 Apr; 77(5):1432-1435. PubMed ID: 35165738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of daptomycin dosage on the clinical outcome in liver transplant recipients with vancomycin-resistant enterococci infection.
    Lee IK; Sng YP; Li WF; Chen CL; Wang CC; Lin CC; Chen IL
    J Chemother; 2022 Oct; 34(6):367-374. PubMed ID: 35075978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?
    Shukla BS; Shelburne S; Reyes K; Kamboj M; Lewis JD; Rincon SL; Reyes J; Carvajal LP; Panesso D; Sifri CD; Zervos MJ; Pamer EG; Tran TT; Adachi J; Munita JM; Hasbun R; Arias CA
    Clin Infect Dis; 2016 Jun; 62(12):1514-1520. PubMed ID: 27045126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting.
    Xie O; Slavin MA; Teh BW; Bajel A; Douglas AP; Worth LJ
    BMC Infect Dis; 2020 Mar; 20(1):228. PubMed ID: 32188401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection.
    Huang ST; Yang JL; Lin CY; Huang SH; Wang JT; Chuang YC; Chen YC; Chang SC
    Int J Infect Dis; 2023 Apr; 129():96-102. PubMed ID: 36736576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients.
    Poutsiaka DD; Skiffington S; Miller KB; Hadley S; Snydman DR
    J Infect; 2007 Jun; 54(6):567-71. PubMed ID: 17188750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.